Since we have some interested parties taking a har
Post# of 9122
If memory serves, under enormous pressure, the FDA allowed some C19 diagnostic tests to be used without FDA approval. But these tests had inherent issues with accuracy and the FDA got burned. I suspect they will now require at least their blessing via the EUA.
I reiterate my musing about who would need to pursue the EUA; the Company or potential licensees. It seems logical that the Company would need to get the EUA only if the plan is to license to multiple partners.
I expect we get some kind of update within the next 2-3-4 weeks. Lack of an update over a longer period of time can be interpreted as news as well. Good on you for deleveraging some risk. I plan to pick up some more shares soon and I probably got some of yours several weeks ago.